These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 17085285)

  • 1. Novel therapies for hereditary angioedema.
    Zuraw BL
    Immunol Allergy Clin North Am; 2006 Nov; 26(4):691-708. PubMed ID: 17085285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress.
    Cugno M; Zanichelli A; Foieni F; Caccia S; Cicardi M
    Trends Mol Med; 2009 Feb; 15(2):69-78. PubMed ID: 19162547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
    Riedl M
    Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonallergic angioedema: role of bradykinin.
    Bas M; Adams V; Suvorava T; Niehues T; Hoffmann TK; Kojda G
    Allergy; 2007 Aug; 62(8):842-56. PubMed ID: 17620062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DX-88 and HAE: a developmental perspective.
    Williams A; Baird LG
    Transfus Apher Sci; 2003 Dec; 29(3):255-8. PubMed ID: 14572818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on hereditary angioedema.
    Hsu D; Shaker M
    Curr Opin Pediatr; 2012 Oct; 24(5):638-46. PubMed ID: 22935756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor.
    Schneider L; Lumry W; Vegh A; Williams AH; Schmalbach T
    J Allergy Clin Immunol; 2007 Aug; 120(2):416-22. PubMed ID: 17559913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on therapeutic developments for hereditary angioedema.
    Christiansen SC; Zuraw BL
    Allergy Asthma Proc; 2009; 30(5):500-5. PubMed ID: 19843404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future therapy for hereditary angioedema.
    Zuraw BL
    Clin Immunol; 2005 Jan; 114(1):10-6. PubMed ID: 15596404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evidence based therapeutic approach to hereditary and acquired angioedema.
    Bork K
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hereditary angioedema--treatment].
    Muszyńska A; Fal AM
    Pol Merkur Lekarski; 2008 Jul; 25(145):94-6. PubMed ID: 18839625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy.
    Kaplan AP
    J Allergy Clin Immunol; 2010 Nov; 126(5):918-25. PubMed ID: 20889195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of hereditary angioedema.
    Davis AE
    Transfus Apher Sci; 2003 Dec; 29(3):195-203. PubMed ID: 14572810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the management of hereditary angioedema.
    Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
    J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
    Castelli R; Zanichelli A; Cugno M
    Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):181-90. PubMed ID: 23137231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathophysiology of hereditary angioedema.
    Davis AE
    Clin Immunol; 2005 Jan; 114(1):3-9. PubMed ID: 15596403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia.
    Longhurst H
    Curr Opin Investig Drugs; 2008 Mar; 9(3):310-23. PubMed ID: 18311668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recombinant human C1-inhibitor is effective in the treatment of acute attacks of hereditary angioedema--case report].
    Porebski G; Bilo B; Obtułowicz K; Obtułowicz P; Nuijens J
    Przegl Lek; 2005; 62(5):317-20. PubMed ID: 16334540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade.
    Busse P; Kaplan A
    J Allergy Clin Immunol Pract; 2022 Mar; 10(3):716-722. PubMed ID: 34838707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.